|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Type 1 Diabetes Mellitus | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 1 | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Immune System Diseases | |||||
| Metabolic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| TRX4 monoclonal antibody | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Antibodies | |||||
| Antibodies, Monoclonal | |||||
| 6 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 7 | Sponsors listed in this trial | ||||
| Tolerx Inc. | |||||
| Juvenile Diabetes Research Foundation (JDRF) | |||||